Superconductivity for addressing global challenges
A CERN event brings together researchers, industry leaders and decision makers to accelerate the use of superconducting technologies for societal applicationsÂ
Advancing cancer therapy with next-gen radionuclides
The PRISMAP programme, coordinated by CERN, has supplied 159 radionuclide batches for cancer research over the past five years
Crystal shadowing to reduce beam losses
A new system made of precisely aligned thin, bent crystal arrays will greatly improve particle beams sent to fixed-target experiments in CERN’s North Area, while also protecting sensitive equipment
A CAS course on advancing cancer therapy with particle accelerators
Particle accelerators have long been synonymous with fundamental physics discoveries, Nobel prizes, new technologies and research at laboratories like CERN.
Superconductivity for addressing global challenges
A CERN event brings together researchers, industry leaders and decision makers to accelerate the use of superconducting technologies for societal applicationsÂ